Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Spectrum Pharmaceuticals files IND with FDA for phosphate-binding agent

Dec. 7, 2011

New triterpenoid derivatives prepared by Concert Pharmaceuticals

Dec. 7, 2011

Novel mineralocorticoid receptor antagonists prepared by Pfizer

Dec. 5, 2011

Novartis discloses final results from EXIST-2 trial

Nov. 30, 2011

Phase III data support lixivaptan therapy in euvolemic hyponatremia

Nov. 29, 2011

Action Pharma presents data from phase II trial of AP-214

Nov. 29, 2011

In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor

Nov. 28, 2011

Phase III study investigates phosphate-lowering effects of SBR-759

Nov. 25, 2011

Astellas Pharma prepares novel NPT-IIb inhibitors

Nov. 24, 2011

Merck & Co. designs novel beta3-adrenoceptor agonists

Nov. 23, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...